Jan 19,2022 12:09 PM
In September 2021 quarter, Lupin logged a consolidated net loss of Rs2,094.9cr.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||808.75||108.74||194,118.20||809.07||0.93||4,120.93||113.47|
|Divis Laboratories Ltd||4,179.40||52.64||110,935.34||606.39||0.48||1,967.86||372.89|
|Dr Reddys Laboratories Ltd||4,496.15||46.28||74,862.73||449.00||0.56||3,809.50||1,049.62|
|Piramal Enterprises Ltd||2,527.85||235.51||60,310.32||34.34||1.23||515.35||962.90|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.Lupin Ltd was incorporated in th... More
C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA
Tell. : +91-22-49186000
Website : www.linkintime.com
Email : email@example.comfirstname.lastname@example.org
Jan 21, 2022 08:35 PM
The company’s consolidated revenue stood at Rs4,504.87cr, up 13.31% yoy and 15.78% qoq.
27 Oct 2021
14 Oct 2021
Quarterly ResultsUnaudited standalone and consolidated financial results for the quarter and half-ye... More
11 Aug 2021
15 Jul 2021
AGM 11/08/2021Proceedings at the Thirty-Ninth Annual General Meeting (AGM) pursuant to Regulation 30... More
Verify your OTP
Didn't receive the OTP yet? Resend